GeoVax Labs, Inc.

About GeoVax Labs, Inc.

GeoVax Labs, Inc. is a clinical-stage biotechnology company focused on developing human vaccines and immunotherapies against infectious diseases and cancer using novel proprietary platforms. Their mission is to serve humanity through innovations in immunology.

Products & Services

Gedeptin(r):A therapy for advanced head and neck cancers, currently in a multicenter Phase 1/2 clinical trial with enrollment completed.

GEO-CM04S1:A next-generation COVID-19 vaccine targeting high-risk, immunocompromised patients, currently in two Phase 2 clinical trials, with a completed Phase 2 trial as a heterologous booster for healthy adults who received an mRNA vaccine.

Preventive Vaccines:Research and development programs for vaccines against Mpox (monkeypox), smallpox, hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg), malaria, and Zika virus.

Therapies for Solid Tumors:Development of therapies targeting various solid tumors.

Specialties

Vaccines for Infectious Diseases Immunotherapies for Cancer COVID-19 Vaccine Development Oncology Therapies MVA Technology

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 5000000 MR: - FA: Approximately $5.0 Million FAN: 5000000	D: 2024-08-28 FD: 2024-08-28	1 investors
2	RT: Grant T: - FT: Grant	A: 45000000 MR: - FA: up to $45 million FAN: 45000000	D: 2024-08-28 FD: 2024-08-28	1 investors
3	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 8500000 MR: - FA: approximately $8.5 million FAN: 8500000	D: 2024-08-20 FD: 2024-08-20	1 investors

Registered Direct Offering Latest

2024-08-28

$5.0M

1 investor (Pro only)

Grant 2024-08-28

$45.0M

Registered Direct Offering 2024-08-20

$8.5M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

O

Olivera (Olja) J. Finn, PhD

Distinguished Professor of Immunology and Surgery

T

Teresa Lambe, PhD, OBE, FMedSci

Calleva Head of Vaccine Immunology and Professor of Vaccinology and Immunology at the University of Oxford

H

Harriet L. Robinson, PhD

Scientific Co-founder, GeoVax

S

Scott C. Weaver, PhD

Director of the University of Texas Medical Branch (UTMB) Institute for Human Infections and Immunity

D

David A. Dodd

Chairman, President & CEO

R

Randal D. Chase, PhD

Biotech Executive and Board Member

View 25 more team members with Pro

Unlock Full Team Directory

Recent News

GeoVax Labs, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised